Halbert Hargrove Global Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Hold
0
– – – 38
2026
Q2
– Hold
0
– – – 38
2026
Q1
– Hold
0
– – – 41
2025
Q4
– Hold
0
– – – 36
2025
Q3
– Hold
0
– – – 45
2025
Q2
– Hold
0
– – – 41
2025
Q1
– Hold
0
– – – 36
2024
Q4
– Hold
0
– – – 40
2024
Q3
– Hold
0
– -$1.54M – 97
2024
Q2
– Hold
0
– – – 35
2024
Q1
– Hold
0
– – – 38
2023
Q4
– Hold
0
– – – 43
2023
Q3
– Hold
0
– – – 41
2023
Q2
– Hold
0
– – – 40
2023
Q1
– Hold
0
– – – 62
2022
Q4
– Hold
0
– – – 57
2022
Q3
– Hold
0
– – – 61
2022
Q2
– Hold
0
– – – 63

Other funds holding LLY

Halbert Hargrove Global Advisors's LLY Position: Q3 2026 in Review

Halbert Hargrove Global Advisors increased its Eli Lilly (LLY) stake by 0.84% in Q3 2026, buying an estimated $15.3K and bringing the position to 1,562 shares worth $1.81M. The position accounts for 0.08% of the portfolio, ranked #37.

Halbert Hargrove Global Advisors first reported a position in LLY in Q1 2015 and has held it in 30 quarters since. The position peaked at $1.94M in Q2 2024. 4,631 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Halbert Hargrove Global Advisors held 1,562 shares of Eli Lilly worth $1.81M as of Q3 2026.
  • Halbert Hargrove Global Advisors bought 13 Eli Lilly shares in Q3 2026, an estimated $15.3K.
  • Eli Lilly made up 0.08% of Halbert Hargrove Global Advisors's portfolio in Q3 2026, its #37 holding.
  • Halbert Hargrove Global Advisors first reported a position in Eli Lilly in Q1 2015 and has held it in 30 quarters since.
  • Halbert Hargrove Global Advisors's Eli Lilly position peaked at $1.94M in Q2 2024.
  • 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Halbert Hargrove Global Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.